Výsledky vyhledávání - "C.A. Egües Dubuc"

FRI0201 OPHTHALMOLOGICAL FEATURES AT DIAGNOSIS AND IN RECURRENCES IN PATIENTS WITH GIANT CELL ARTERITIS CONFIRMED BY BIOPSY IN A TERTIARY HOSPITAL

Autor: J. A. Valero Jaimes, A. C. Blanco Esteban, E. Uriarte Isacelaya, C.A. Egües Dubuc, A. De Diego Sola, N. Alcorta Lorenzo, O. Maiz-Alonso, J. J. Cancio Fanlo, J. M. Belzunegui Otano

Publikováno v: Annals of the Rheumatic Diseases. 79:684.2-684

Background:Giant cell arteritis (GCA) presents with visual symptoms in approximately 37%1of patients at diagnosis. Patients with visual symptoms present, according to some series, lower levels of C-reactive protein (CRP) at diagnosis and associate le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30ca0fcb5e633aebb4ea2097eeed6dec
https://doi.org/10.1136/annrheumdis-2020-eular.5911

Zobrazit plný text záznamu

FRI0481 HEMOPHAGOCYTIC SECONDARY SYNDROME. DIFFERENCES BETWEEN AUTOIMMUNE AND HEMATO-ONCOLOGICAL ETIOLOGIES

Autor: J. A. Valero Jaimes, A. De Diego, C.A. Egües Dubuc, J. Calvo, O. Maiz-Alonso, J. R. Furundarena Salsamendi, L. M. Lopez Dominguez, P. Cabrera Miranda, J. M. Belzunegui Otano, J. J. Cancio Fanlo, E. Uriarte Isacelaya, N. Alcorta Lorenzo

Publikováno v: Annals of the Rheumatic Diseases. 79:837.2-838

Background:The Hemophagocytic Syndrome (HPS) is has been classified into 2 groups: primary and secondary. The secondary form is mainly associated with hemato-oncological diseases (HOD) and autoimmune diseases (AID). The present work aims to obtain cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0b1198ad74e1388c9e8e4f585ac2540
https://doi.org/10.1136/annrheumdis-2020-eular.4688

Zobrazit plný text záznamu

SAT0516 CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PATIENTS WITH SECONDARY HEMOPHAGOCYTIC SYNDROME

Autor: P. Cabrera Miranda, O. Maiz-Alonso, A. De Diego, N. Alcorta Lorenzo, E. Uriarte Isacelaya, C.A. Egües Dubuc, J. M. Belzunegui Otano, J. J. Cancio Fanlo, J. A. Valero Jaimes, J. Calvo, L. M. Lopez Dominguez, J. R. Furundarena Salsamendi

Publikováno v: Annals of the Rheumatic Diseases. 79:1214.2-1214

Background:The Hemophagocytic Syndrome (HPS) had a mortality rate between 20% and 90%. The mortality of HPS secondary to autoimmune diseases (AID) is lower than hemato-oncological diseases (HOD). In general, the HOD, thrombocytopenia, age, and a prol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3619913b7453119228133e5175dec8eb
https://doi.org/10.1136/annrheumdis-2020-eular.5855

Zobrazit plný text záznamu

SAT0604 Secondary hemophagocytic syndrome: retrospective study according to the underlying disease

Autor: L.M. López, E. Uriarte, M.M. Yagüe, J.R. Furundarena, C.A. Egües Dubuc, J. Cancio, A. De Diego, J. Belzunegui, O. Maíz, J.A. Valero, J. Calvo Alén

Publikováno v: Saturday, 16 JUNE 2018.

Background Secondary Hemophagocytic Syndrome (SHS) is associated with Hematoncologic (HO), Autoimmune (AI) diseases [such as Systemic Lupus Erythematosus (SLE) or Adult’s Still Disease (ASD)] and in a lower frequency with Infections (Inf.) and Tumo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72f10609b37db0934ac509aaded18904
https://doi.org/10.1136/annrheumdis-2018-eular.6184

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

THU0542 Is there Any Difference Between Autoimmune or Hemato-Oncology Etiology to Guide us in the Diagnosis of Secondary Macrophage Activation Syndrome?: Table 1

Autor: C.A. Egües Dubuc, I. Hernando Rubio, E. Uriarte Isacelaya, J. M. Belzunegui Otano, N. Errazquin Aguirre, C. Meneses Villalba, M. Uriarte Ecenarro, O. Maiz Alonso, V. Aldasoro Cáceres, M. Yague Asensio, J. J. Cancio Fanlo

Publikováno v: Annals of the Rheumatic Diseases. 74:396.2-396

Background Secondary macrophage activation syndrome (MAS) is a group of diseases, especially due to autoimmune (AI) and hemato-oncology (HO). It would be interesting to find any clinical and analytics data to differentiate both etiologies. Objectives

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::94580b375ef5ad411830b15ee4671801
https://doi.org/10.1136/annrheumdis-2015-eular.3006

Zobrazit plný text záznamu

AB0921 Secondary Macrophage Activation Syndrome: Report of 13 Clinical Cases and the Difference between the 4 Groups of Diseases: Table 1

Autor: M. Yague Asensio, I. Hernando Rubio, I. Bañegil Espinoza, E. Uriarte Isacelaya, O. Maiz Alonso, C. Meneses Villalba, C.A. Egües Dubuc, M. Uriarte Ecenarro, N. Errazquin Aguirre, J. J. Cancio Fanlo, J. M. Belzunegui Otano

Publikováno v: Annals of the Rheumatic Diseases. 73:1104.3-1105

Background The secondary macrophage activation syndrome (SMAS) is a group of diseases that include the: Autoimmune (AI), Hemato-Oncological (HO), Infectious (Inf) and Oncological (Onco). We make a review of the the cases presented in a our hospital.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd6995ff24b3c4129f7625f2e1754756
https://doi.org/10.1136/annrheumdis-2014-eular.5055

Zobrazit plný text záznamu

THU0452 Secondary Hemophagocytic Lymphohistiocytosis: A Series of 11 Patients. Literature Review

Autor: C.A. Egües Dubuc, I. Hernando Rubio, C. Meneses Villalba, V. Aldasoro Cáceres, M. Ecenarro Uriarte, J. Belzunegui Otano

Publikováno v: Annals of the Rheumatic Diseases. 72:A317.2-A317

Background Hemophagocytic Lymphohistiocytosis (HLH) is a severe and acute inflammatory syndrome, underdiagnosed, difficult to treat and can occur at any stage of life. The macrophage activation syndrome is a variant of secondary HLH occurs in autoimm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5d6005858f66d918c4a905f44dcb065
https://doi.org/10.1136/annrheumdis-2013-eular.980

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání